{"id":194559,"name":"PECK MADIGAN JONES (ON BEHALF OF ROIVANT SCIENCES, INC.)","slug":"peck-madigan-jones-on-behalf-of-roivant-sciences-inc","state":"DC","country":"United States of America","description":"Biopharmaceutical drug development.","totalSpending":0,"filings":11,"yearlySpending":[{"year":2018,"income":0},{"year":2019,"income":0},{"year":2020,"income":0}],"issues":[{"code":"PHA","display":"Pharmacy"},{"code":"HCR","display":"Health Issues"}],"firms":["TIBER CREEK HEALTH STRATEGIES, INC."],"lobbyists":["JAMES HALL"],"govEntities":["SENATE"],"sampleDescriptions":["Issues related to healthcare, the Food and Drug Administration, and pharmaceuticals.","Issues related to healthcare, the Food and Drug Administration, and pharmaceuticals.","Issues related to drug development, Womens health issues","Issues pertaining to womens health and treatment of endometriosis; treatment of rare diseases; Issues related to the development of new treatments and therapies","Issues related to drug development, Womens health issues"]}